Which funds bought or sold NU in Q3 2026?
Nu Hldgs Ltd. 9 funds bought, 9 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$428M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Capital Research+$426M
- Morgan Stanley+$379M
- UBS+$181M
- Man Group+$160M
- Arrowstreet+$143M
- Baillie Gifford+$101M
- D1+$83M
- Maverick+$15M
- ARK+$1M
- Goldman Sachs−$240M
- CPP Investments−$124M
- Marshall Wace−$105M
- Susquehanna−$74M
- CalPERS−$22M
- Sands Capital−$19M
- SoftBank−$13M
- Palestra−$13M
- Polen−$8M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (9)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Capital Research Asset manager | Added+23.6% | +$426M | $2.2B |
| Morgan Stanley Bank & broker | Added+25.4% | +$379M | $1.9B |
| UBS Bank & broker | Added+130.2% | +$181M | $320M |
| Man Group Quant & multi-strategy | Added+1128% | +$160M | $174M |
| Arrowstreet Quant & multi-strategy | Added+46.6% | +$143M | $450M |
| Baillie Gifford Growth / crossover | Added+3.5% | +$101M | $3.0B |
| D1 Growth / crossover | Added+14.8% | +$83M | $645M |
| Maverick Hedge fund | Added+3.3% | +$15M | $465M |
| ARK Growth / crossover | Added+10.1% | +$1M | $15M |
Sold (9)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Goldman Sachs Bank & broker | Trimmed-62.5% | −$240M | $144M |
| CPP Investments Sovereign & pension | Trimmed-69.3% | −$124M | $55M |
| Marshall Wace Quant & multi-strategy | Trimmed-91.4% | −$105M | $10M |
| Susquehanna Quant & multi-strategy | Trimmed-52% | −$74M | $69M |
| CalPERS Sovereign & pension | Trimmed-25.9% | −$22M | $62M |
| Sands Capital Growth / crossover | Trimmed-12.2% | −$19M | $139M |
| SoftBank Venture capital | Trimmed-5.6% | −$13M | $213M |
| Palestra Hedge fund | Trimmed-7.1% | −$13M | $165M |
| Polen Growth / crossover | Trimmed-86.8% | −$8M | $1M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.